Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.
暂无分享,去创建一个
F. Tsai | D. Bau | Yung‐Li Yang | D. Lin | C. Wang | C. Peng | Kang-Hsi Wu | Wei‑De Lin | Wei-De Lin
[1] H. Wang,et al. Significant association of DNA repair gene Ku80 genotypes with breast cancer susceptibility in Taiwan. , 2009, Anticancer research.
[2] Hsi-Chin Wu,et al. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.
[3] Chia-Wen Tsai,et al. Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan. , 2009, Anticancer research.
[4] M. Tsai,et al. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer susceptibility. , 2009, Oral oncology.
[5] Mei-Due Yang,et al. Significant association of Ku80 single nucleotide polymorphisms with colorectal cancer susceptibility in Central Taiwan. , 2009, Anticancer research.
[6] Hsi-Chin Wu,et al. Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.
[7] D. Bau,et al. Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan. , 2009, Anticancer research.
[8] Hsi-Chin Wu,et al. Significant association of Ku80 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.
[9] Hsi-Chin Wu,et al. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. , 2009, Anticancer research.
[10] M. Tsai,et al. Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. , 2008, Oral oncology.
[11] Da-Tian Bau,et al. A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. , 2008, Oral oncology.
[12] M. Tsai,et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. , 2008, Anticancer research.
[13] Chen-Yang Shen,et al. A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. , 2008, Anticancer research.
[14] M. Tsai,et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. , 2008, Oral oncology.
[15] D. Bau,et al. A Novel Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Gastric Cancer Susceptibility in Taiwan , 2008, Annals of Surgical Oncology.
[16] Jeroen A. A. Demmers,et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4 , 2006, Proceedings of the National Academy of Sciences.
[17] Chen-Yang Shen,et al. The role of BRCA1 in non-homologous end-joining. , 2006, Cancer letters.
[18] Nicola J. Camp,et al. A Role for XRCC4 in Age at Diagnosis and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.
[19] Richard G. W. Anderson,et al. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization , 2005, Nature Cell Biology.
[20] John N. Hutchinson,et al. Caveolin-1 Gene Disruption Promotes Mammary Tumorigenesis and Dramatically Enhances Lung Metastasis in Vivo , 2004, Journal of Biological Chemistry.
[21] Chen-Yang Shen,et al. Breast Cancer Risk and the DNA Double-Strand Break End-Joining Capacity of Nonhomologous End-Joining Genes Are Affected by BRCA1 , 2004, Cancer Research.
[22] D. van Heemst,et al. End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. , 2004, DNA repair.
[23] K. Matsubara,et al. [FISH detected 11q23 microdeletion and translocation at the long arm of chromosome 11 in a child with normal karyotypic acute lymphoblastic leukemia]. , 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[24] P. Malfertheiner,et al. Expression of caveolin-1 in gastrointestinal and extraintestinal cancers , 2003, Journal of Cancer Research and Clinical Oncology.
[25] Chen-Yang Shen,et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. , 2003, Cancer research.
[26] Pan‐Chyr Yang,et al. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.
[27] P. Nathan,et al. Isochromosome (17)(q10) and translocation (4;12)(q12;p13) in a child with acute myeloid leukemia. , 2001, Cancer genetics and cytogenetics.
[28] M Dietel,et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. , 2001, The American journal of pathology.
[29] T. Timme,et al. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis , 2000, Oncogene.
[30] F. Alt,et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development , 2000, Nature.
[31] J. Engelman,et al. p42/44 MAP Kinase-dependent and -independent Signaling Pathways Regulate Caveolin-1 Gene Expression , 1999, The Journal of Biological Chemistry.
[32] F. Alt,et al. A Critical Role for DNA End-Joining Proteins in Both Lymphogenesis and Neurogenesis , 1998, Cell.
[33] T. Seya,et al. Expression of caveolin-1 in human T cell leukemia cell lines. , 1998, Biochemical and biophysical research communications.
[34] Jan E Schnitzer,et al. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells , 1998, Oncogene.
[35] F. Alt,et al. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination , 1995, Cell.